| Tag | Content |
|---|
EnhancerAtlas ID | HS109-12348 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:85056870-85057680 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESRRB | MA0141.3 | chr2:85057557-85057568 | AATGACCTTGA | - | 6.32 | | Esrra | MA0592.2 | chr2:85057558-85057569 | ATGACCTTGAA | - | 6.62 | | Esrrg | MA0643.1 | chr2:85057558-85057568 | ATGACCTTGA | - | 6.02 | | RREB1 | MA0073.1 | chr2:85056912-85056932 | CCACATACCACACACACCCC | + | 6.14 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_17329 | chr2:85054197-85062624 | CD4p_CD25-_CD45RAp_Naive | | SE_18307 | chr2:85054164-85062644 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I084829 | chr2 | 85056725 | 85061432 |
|
Enhancer Sequence | CCAGCCATGT TCCACACACA TCCACACTAC ACCACACACA CCCCACATAC CACACACACC 60
CCTCACACAC AGGTACCAAA CAACACACAT ACCAGACATG CACCACACAC ACACCATACA 120
CATGCACACT ACACACACAC ACATACACCC CACACATATT CCACACTAGA TACACACCAC 180
ACAAACCCTA CACACAAACA TCACACACAA CACACCCCTC ACACACACCA CACACCAGAC 240
ACACACAAAC ACAAACATTA CATACTCCAC ACACATTACA CCACACACAC GTACACACTC 300
CCCAGGTAGG GCCCTCTCCA GCACCCTAAG GACAGTGCGT TGAACCCCAG GCCAGTCAGC 360
CCAGCGGGAA GAGCTGAGAA GGGACCAGAG GCCAGTGAGG GAGGAAAGAC CCACAGTCCT 420
GCAGGGCGCA GAGAACCCCT AAGGGCTGGC TCCTCCAGAC CTGCAGGAGA ACAGGAAGGA 480
GAGAGGCAGG AGACGTGAGC CTGCAACAGA GCTGACTCAG GCAGGGGCGG GATCCTCCCG 540
GTCAAGGGGA GGAGAGGAGG GCTCCTCAGA AGGGGGAAGT AGCGTCAGTA AAGGAGAGGC 600
GGGGACGGGA TGGAGGCTCT TCTGAAGCAA GCAGCAGATC CATGCTGGAA GGGTAGGGTC 660
TGAGTGCCAA GACCTCCGCG TGAAGACAAT GACCTTGAAA AAGAACAACA TGAAACCACG 720
GAGGGTTTGA ATATAGGACA CTGGAAAGAA TAGTCCCACA GAAGGGCGAA GAGTGAACCA 780
GAGGGAGAAG GGCCTGGAAG GGGGCGGTGG 810
|
